Chicago Partners Investment Group LLC
Position in DFTX — Definium Therapeutics, Inc.
CIK 1563525
CHICAGO, IL
Position in DFTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$343,344
+$167,442 QoQ
Shares Held
7,299
-21.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#240
of 358 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in DFTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Chicago Partners Investment Group LLC holds $16,750,273 across 43 Biotechnology names. DFTX ranks #15 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TSHA |
Taysha Gene Therapies, Inc.
|
222,347 | $1,514,183 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,209 | $1,377,399 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
5,326 | $1,283,406 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,455 | $1,219,472 | |
| 5 | CING |
Cingulate Inc.
|
188,429 | $1,030,706 | |
| 6 | EXEL |
Exelixis, Inc.
|
18,752 | $1,020,296 | |
| 7 | RPRX |
Royalty Pharma plc
|
14,923 | $836,732 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
12,109 | $692,876 |
All Filings in DFTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $343,344 | 7,299 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $175,902 | 9,307 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||